Evidence map›Paper›PMID 35031640›Full record

ArticleScientific reports2022

Association of plasma tryptophan concentration with periaqueductal gray matter functional connectivity in migraine patients.

Kinga Gecse, Dóra Dobos, Csaba Sándor Aranyi, Attila Galambos, Daniel Baksa, Natália Kocsel, Edina Szabó, Dorottya Pap, Dávid Virág, Krisztina Ludányi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Kinga GecseDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvarad ter 4, Budapest, 1089, Hungary.
Dóra DobosDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvarad ter 4, Budapest, 1089, Hungary.
Csaba Sándor AranyiDivision of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Attila GalambosSE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Daniel BaksaDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvarad ter 4, Budapest, 1089, Hungary.
Natália KocselSE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Edina SzabóSE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Dorottya PapSE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Dávid VirágDepartment of Pharmaceutics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Krisztina LudányiDepartment of Pharmaceutics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Gyöngyi KökönyeiDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvarad ter 4, Budapest, 1089, Hungary.
Miklós EmriDivision of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Gyorgy BagdyDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvarad ter 4, Budapest, 1089, Hungary.
Gabriella JuhaszDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvarad ter 4, Budapest, 1089, Hungary. juhasz.gabriella@pharma.semmelweis-univ.hu.
Semmelweis University · HUEötvös Loránd University · HUUniversity of Debrecen · HU

Funding

Development of scientific workshops of medical, health sciences and pharmaceutical educations EFOP-3.6.3-VEKOP-16-2017-00009Magyar Tudományos Akadémia 2017-1.2.1-NKP-2017-00002Ministry for Innovation and Technology in Hungary 2020-4.1.1.-TKP2020Nemzeti Kutatási, Fejlesztési és Innovaciós Alap ÚNKP-20-3-II-SE-51Nemzeti Kutatási Fejlesztési és Innovációs Hivatal 2019-2.1.7-ERA-NET-2020-00005
6 · The paper itself

Abstract

Altered periaqueductal gray matter (PAG) functional connectivity contributes to brain hyperexcitability in migraine. Although tryptophan modulates neurotransmission in PAG projections through its metabolic pathways, the effect of plasma tryptophan on PAG functional connectivity (PAG-FC) in migraine has not been investigated yet. In this study, using a matched case-control design PAG-FC was measured during a resting-state functional magnetic resonance imaging session in migraine without aura patients (n = 27) and healthy controls (n = 27), and its relationship with plasma tryptophan concentration (TRP) was assessed. In addition, correlations of PAG-FC with age at migraine onset, migraine frequency, trait-anxiety and depressive symptoms were tested and the effect of TRP on these correlations was explored. Our results demonstrated that migraineurs had higher TRP compared to controls. In addition, altered PAG-FC in regions responsible for fear-cascade and pain modulation correlated with TRP only in migraineurs. There was no significant correlation in controls. It suggests increased sensitivity to TRP in migraine patients compared to controls. Trait-anxiety and depressive symptoms correlated with PAG-FC in migraine patients, and these correlations were modulated by TRP in regions responsible for emotional aspects of pain processing, but TRP did not interfere with processes that contribute to migraine attack generation or attack frequency.

Indexed as

Synaptic TransmissionAnxietyCase-Control StudiesDepressionEmotionsFemaleHumansMagnetic Resonance ImagingMaleMigraine DisordersPain PerceptionPeriaqueductal GrayTryptophanTryptophan

Identifiers

PMID35031640
PMCPMC8760301
OpenAlexW4206644086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.